Li Ma1, Roger Arthur Zwahlen, Li Wu Zheng, Mai Har Sham. 1. Department of Oral & Maxillofacial Surgery, The Prince Philip Dental Hospital, Faculty of Dentistry, The University of Hong Kong, Hong Kong, SAR China. lima@hku.hk
Abstract
OBJECTIVES: To assess the influence of nicotine on the proliferation and gene expression of osteogenic and angiogenic mediators of osteoblasts. MATERIAL AND METHODS: Rabbit primary osteoblasts were exposed to various concentrations of nicotine (0.001, 0.1 and 10 μmol/l). The cell proliferation was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. The gene expression of transforming growth factor (TGF)-β(1), bone morphogenetic protein (BMP)-2, platelet-derived growth factor (PDGF)-AA and vascular endothelial growth factor (VEGF) was evaluated using real-time reverse transcription - polymerase chain reaction. RESULTS: The osteoblast proliferation was inhibited by nicotine at the concentration of 0.001-10 μM at 48 and 72 h of culture, but with no significant effect at 24 h. The expression of TGF-β(1), BMP-2, PDGF-AA and VEGF was inhibited by nicotine at the concentrations of 0.1 and 10 μM, but with no significant difference at the low concentration of 0.001 μM. CONCLUSIONS: Nicotine suppresses osteoblast proliferation and inhibits the expression of some key osteogenic and angiogenic mediators in the in vitro experimental model. These inhibitory effects of nicotine on the osteoblast activity may reflect, to a certain degree, the overall detrimental effects of tobacco use on the survival rate of dental implants.
OBJECTIVES: To assess the influence of nicotine on the proliferation and gene expression of osteogenic and angiogenic mediators of osteoblasts. MATERIAL AND METHODS:Rabbit primary osteoblasts were exposed to various concentrations of nicotine (0.001, 0.1 and 10 μmol/l). The cell proliferation was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. The gene expression of transforming growth factor (TGF)-β(1), bone morphogenetic protein (BMP)-2, platelet-derived growth factor (PDGF)-AA and vascular endothelial growth factor (VEGF) was evaluated using real-time reverse transcription - polymerase chain reaction. RESULTS: The osteoblast proliferation was inhibited by nicotine at the concentration of 0.001-10 μM at 48 and 72 h of culture, but with no significant effect at 24 h. The expression of TGF-β(1), BMP-2, PDGF-AA and VEGF was inhibited by nicotine at the concentrations of 0.1 and 10 μM, but with no significant difference at the low concentration of 0.001 μM. CONCLUSIONS:Nicotine suppresses osteoblast proliferation and inhibits the expression of some key osteogenic and angiogenic mediators in the in vitro experimental model. These inhibitory effects of nicotine on the osteoblast activity may reflect, to a certain degree, the overall detrimental effects of tobacco use on the survival rate of dental implants.
Authors: Hildemberg A R Santiago; Ariane Zamarioli; Manoel D Sousa Neto; Jose B Volpon Journal: Clin Orthop Relat Res Date: 2016-11-30 Impact factor: 4.176
Authors: Seham Salem Ahmed Abukhadir; Norazlina Mohamed; Suzana Makpol; Norliza Muhammad Journal: Evid Based Complement Alternat Med Date: 2012-08-28 Impact factor: 2.629